Plea to radiologists: Please consider Mahvash disease when encountering an enlarged pancreas
Radiologists play a key role in establishing an early and accurate diagnosis, especially for rare diseases. Mahvash disease (OMIM 619290) is an autosomal recessive hereditary disease caused by inactivating mutations of the glucagon receptor and its main clinical consequences are pancreatic neuroendo...
Saved in:
Published in | World journal of radiology Vol. 16; no. 8; pp. 371 - 374 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
United States
Baishideng Publishing Group Inc
28.08.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Radiologists play a key role in establishing an early and accurate diagnosis, especially for rare diseases. Mahvash disease (OMIM 619290) is an autosomal recessive hereditary disease caused by inactivating mutations of the glucagon receptor and its main clinical consequences are pancreatic neuroendocrine tumors and in some cases, porto-sinusoidal vascular disease and portal hypertension. Untreated Mahvash disease can be lethal. The diagnosis of Mahvash disease has almost always been delayed in the past due to radiologists' unawareness of or unfamiliarity with the unique imaging features of Mahvash disease which are moderately to enormously enlarge pancreas with preserved pancreas contour and parenchyma without vascular involvement or lymphadenopathy. These features help differentiate Mahvash disease from other etiologies of diffusely enlarged pancreas such as diffuse pancreatic ductal carcinoma, diffuse pancreatic lymphoma, and autoimmune pancreatitis. Invoking Mahvash disease in the differential diagnosis of an enlarged pancreas has recently been shown to facilitate early diagnosis. To prevent missing the diagnosis of this significant disease, I sincerely ask radiologists to consider Mahvash disease in their differential diagnoses of diffusely enlarged pancreas. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author contributions: Yu R wrote the paper. Corresponding author: Run Yu, MD, PhD, Professor, Division of Endocrinology, Diabetes, and Metabolism, University of California at Los Angeles, David Geffen School of Medicine, 200 Medical Plaza Driveway 530, Los Angeles, CA 90095, United States. runyu@mednet.ucla.edu |
ISSN: | 1949-8470 1949-8470 |
DOI: | 10.4329/wjr.v16.i8.371 |